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Obesity-related hormonal and metabolic alterations implicated in colorectal carcinogenesis are mainly driven by visceral adipose tissue (VAT) rather than subcutaneous adipose tissue (SAT).  Yet, most epidemiologic studies have examined the relationship between excess adiposity and colorectal neoplasia using a surrogate marker of VAT such as body mass index (BMI) and waist circumference (WC).  Due to the inability of BMI and WC to distinguish VAT from SAT, they have beenare likely to have underestimated the true harmful association.

Objective 
We conducted a dose-response meta-analysis to summarize the relationships between visceral adiposity and colorectal adenomas and to examine the value ofan independent predictability of VAT as an independent predictor beyond BMI, WC, SAT. 

Data Sources
PubMed and Embase were searched through September, 2014. 

Study Selection
Observational studies investigating the relationship between VAT as measured by CT or MRI and adenomas were included.

Data Extraction and Synthesis
Data were extracted independently by two authors and inconsistency was checked by a third author.  Summary odds ratio (OR) was estimated using a random-effects model. 





In linear dose-response meta-analysis, the summary odds ratio (OR) for each 25 cm2 increase in VAT area was 1.13 (95% CI=1.05-1.21; I2=62%; 6 studies; 2,776 cases; range of VAT area=30-228 cm2). The dose-response curve suggested no evidence of non-linearity (Pnon-linearity=0.37).  In meta-analysis comparing the highest vs. lowest category of VAT based on 12 studies, a positive association between VAT and adenomas remained statistically significant even after adjustment for BMI, WC, and SAT.  In contrast, adjustment for VAT substantially attenuated associations of BMI, WC, and SAT with adenomas.  Across the studies, VAT was more strongly associated with advanced adenomas than non-advanced adenomas.    

Conclusions and relevance 
VAT may be the underlying mediator of the observed associations of BMI and WC with adenomas, continuing to increase adenoma risk over a wide range of VAT area.





Adipose tissue, once regarded as a simple reservoir of excess calories, is now recognized as an active endocrine and metabolic organ.  Excess adiposity results in an elevation in circulating concentrations of insulin and bioavailable IGF-I, ADDIN EN.CITE 1 which promotes colorectal carcinogenesis by enhancing proliferation and inhibiting apoptosis of colonocytes. ADDIN EN.CITE 2  Epidemiologic studies have shown that the amount (i.e. overall adiposity) and distribution (i.e. abdominal vs. non-abdominal obesity) of excess adiposity as assessed by body mass index (BMI) and waist circumference (WC), respectively, are independent predictors of colorectal neoplasia.3  Yet, emerging evidence suggests the importance of distinguishing visceral adipose tissue (VAT) surrounding the internal organs from subcutaneous adipose tissue (SAT) located beneath the skin, above and beyond the amount and distribution of adipose tissue.4

SAT and VAT have different metabolic consequences.  Relative to SAT, VAT is more strongly associated with insulin resistance. VAT secretes more pro-inflammatory cytokines (e.g., interleukin-6, tumor necrosis factor-α) and less adiponectin, which contributes to insulin resistance. ADDIN EN.CITE 4,5  Furthermore, VAT is more lypolytic, effusing free fatty acids into the circulation.6  To regulate the rise in plasma free fatty acids levels, the liver and muscle become less responsive to insulin (i.e. insulin resistance), preferentially uptaking and oxidizing fatty acids over glucose. ADDIN EN.CITE 1,6  The hyperinsulinemia resulting from insulin resistance suppresses hepatic production of hormonal binding proteins (e.g. IGFBP), which in turn increases bioavailability of IGF-I. ADDIN EN.CITE 1  Due to the critical role of VAT in elevating circulating levels of insulin and bioavailable IGF-I, it has been hypothesized that observed associations of BMI and WC with colorectal neoplasia may be mainly mediated by VAT.  Indeed, in a study that compared various indices of adiposity including SAT, VAT, and total abdominal adipose tissue (SAT+VAT), BMI, and WC, only VAT was a statistically significant determinant of colorectal neoplasia. ADDIN EN.CITE 7  






	The Meta-analysis Of Observational Studies in Epidemiology (MOOSE) checklist8 was followed for the design, analysis, and reporting of this meta-analysis.  Two authors (DL and RK) participated in literature search, study selection, and data extraction independently.  Inconsistency between researchers was resolved through discussion with a third author (NK).

Literature Search
	PubMed and Embase databases were searched for studies published up to August 2014. Detailed search terms are provided (eTable 1).  The language was limited to English and no other restrictions were imposed.  Abstracts and unpublished results were not included.  The reference lists of all the articles included in this analysis were also reviewed for additional studies.

Study Selection




	From each study, the following information was extracted: the most fully adjusted OR and corresponding 95% CI in each category of VAT, category-specific range of VAT, category-specific or total number of cases, category-specific or total number of noncases, unit (cm2, cm3) and assessment method (anatomic site, machine used) of VAT, adenoma subtype, first author's name, publication year, study design, study population (country, sex, age at enrollment), adjustment variables. 

Statistical Analysis
In the investigation of objectively-assessed exposure and asymptomatic outcome, point estimates from cross-sectional and case-control studies become more comparable, because difference by study design in their susceptibility to each bias becomes less pronounced.  For example, as VAT was measured by a medical equipment rather than self-reported by participants, participants’ knowledge of their disease status at VAT assessment did not lead to recall bias in case-control studies.  Likewise, as asymptomatic adenomas are detectable only at time of endoscopy, source population was defined as subjects who underwent an endoscopy across the study designs.  Given the well-defined primary source population from which both cases and controls are easily sampled, selection bias was less likely in case-control studies.  For these reasons, both cross-sectional and case-control studies were analyzed together in dose-response meta-analysis.  
Furthermore, while measurement of VAT area (cm2) was relatively standardized, studies varied in abdominal region over which VAT volume (cm3) was quantified, which made VAT volume non-comparable across studies.  Thus, dose-response meta-analysis was conducted only among studies that measured VAT area (6 studies ADDIN EN.CITE 7,10-14 out of the 10 eligible studies ADDIN EN.CITE 7,10-18).
For linear dose-response meta-analysis assuming a linear relationship between visceral adiposity as measured by VAT area and adenoma risk, the method described by Greenland and Longnecker21 was used to calculate study-specific ORs (linear slopes) and 95% CIs from the correlated ORs and 95% CIs extracted across different categories of VAT area.  In estimating study-specific linear trends, several approximations were made: the midpoint of VAT area in each category was assigned to the corresponding OR; the width of the open-ended extreme categories was assumed to be the same as that of the adjacent interval; when the range of VAT area for each category was given separately for men and women, weighted average of the two midpoints using the number of each sex as the weight was assigned to the corresponding OR. ADDIN EN.CITE 12,14; when the distributions of cases and non-cases were not provided, they were estimated if the analysis was based on quantiles and category-specific crude ORs and total number of cases and noncases were given. ADDIN EN.CITE 11,12 Then, the estimated study-specific ORs and variances were pooled using a random effects model to calculate the summary OR and 95% CI.  Forest plots of the linear dose-response meta-analysis were presented for ORs for each 25cm2 increment in VAT area (a unit area equivalent to the area of a square with sides of 5 cm).  
	 To examine any potential non-linear relationship between VAT area and adenoma risk, non-linear dose-response meta-analysis was performed based on the restricted cubic spline approach. ADDIN EN.CITE 22,23  Of note, this approach requires that studies have more than three categories of VAT area.  For each study, cubic splines were modeled with three knots fixed at percentiles (10%, 50%, and 90%) of the whole distribution of VAT area, accounting for correlation across category-specific ORs and 95% CIs within each study.22  This approach requires that studies have more than three categories of VAT area. The reference was set to 29.8 cm2, the lowest value of the reported VAT area.  Then, the derived curves were combined using multivariate random-effects meta-analysis.24  The p-value for nonlinearity was obtained from the test of the null hypothesis that the regression coefficient of the second spline transformation was equal to zero.  
Heterogeneity in the relationship between VAT area and adenomas across studies was tested by Cochran’s Q test25 and quantified by the percentage of total variation across studies that is attributable to heterogeneity (I2).26  Subgroup analyses and meta-regression were conducted based on linear dose-response meta-analysis by a priori selected variables related to potential effect modifiers to identify sources of heterogeneity; by variables concerning methodological characteristics to assess study quality.  Due to insufficient data, etiology heterogeneity by adenoma subtype was explored qualitatively.  Potential for small study effects, ADDIN EN.CITE 27,28 such as publication bias, was assessed visually using funnel plots and statistically using Egger's test.29  To check robustness of the results, diverse sensitivity analyses were performed including the influence analysis, repeating linear dose-response meta-analysis excluding the three studies ADDIN EN.CITE 11,12,14 that made additional approximations, and highest vs. lowest meta-analysis that pooled ORs for the extreme categories of VAT area or volume using a random effects model based on the 12 studies. ADDIN EN.CITE 7,10-20  
	To compare the predictive ability of VAT with that of other adiposity indices (BMI, WC, SAT), additional highest vs. lowest meta-analyses were performed based on the all 12 studies identified. ADDIN EN.CITE 7,10-20  First, tTo see investigate whether if VAT is associated with adenomas independent over and above of the other adiposity indices, for each of BMI, WC, and SAT, we compared two summarythe pooled ORs for VAT without adjustment for BMI, WC, or SAT, with the pooled OR adjusting (one unadjusted for, the other additionally adjusted for the another adiposity index (BMI, WC or SAT). This  estimated comparison was restricted tofrom studies that provided both the unadjusted and adjusted ORs.  Second, conversely, tTo see investigate if adjustment for VAT attenuates abolishes associations between the other adiposity indices and adenomas, for each measure of adiposity we compared the pooled OR unadjusted for VAT with the pooled OR adjusting for VAT, restricting analyses to studies that presented both adjusted and unadjusted analyses.two summary ORs for each of BMI, WC, and SAT (one unadjusted for VAT, the other adjusted for VAT) estimated from studies that provided both the unadjusted and adjusted ORs.  ThirdIn addition, as a sensitivity analysis, we compared the summary ORs for each of VAT, BMI, WC, and SAT that were not mutually adjusted for, which were estimated from studies that provided mutually unadjusted ORs for VAT and for at least one of the other adiposity indices.








In the linear dose-response meta-analysis of six studies (3 cross-sectional, 3 case-control studies), ADDIN EN.CITE 7,10-14 a total of 2,776 cases were included with category-specific midpoints of VAT area ranging from 30 to 228 cm2.  The summary OR for each 25 cm2 increase in VAT area was 1.13 (95% CI=1.05-1.21), with moderate heterogeneity (I2=62%, Pheterogeneity=0.02) (Figure 2A).  Small study effects, such as publication bias, were not indicated by the funnel plot (symmetrical shape, figure not shown) and Egger's test (P=0.81).  In sensitivity analyses excluding one study at a time, the results did not change materially (data not shown).  Yet, upon excluding the study by Kang et al., ADDIN EN.CITE 12 that showed the strongest association, the attenuated summary association was statistically significant with no evidence of heterogeneity (OR=1.09, 95% CI=1.04-1.14, I2=0%, Pheterogeneity=0.77).  When the analysis was conducted excluding the three studies ADDIN EN.CITE 11,12,14 that made additional approximations, the results did not change materially except for a markedly reduced heterogeneity (OR=1.12, 95% CI=1.04-1.21, I2=0%, Pheterogeneity=0.80).  In the non-linear dose-response meta-analysis, five studies ADDIN EN.CITE 7,10-12,14 were included (2,690 cases, range=30-227 cm2), after excluding one study ADDIN EN.CITE 13 that analyzed VAT area in three categories only.  The dose-response curve suggested no evidence of non-linearity (Pnon-linearity=0.37) (Figure 2B).  Compared to 30 cm2 of VAT area, the summary OR was 1.48 (95% CI=1.31-1.66) at 90 cm2 and increased to 1.98 (95% CI=1.75-2.24) at 150 cm2.     
To explore robustness of a statistically significant direct association in the most inclusive dataset, highest vs. lowest meta-analysis was performed by additionally including studies that were not eligible for the dose-response meta-analysis (i.e. four studies that assessed VAT in volume; two studies that provided ORs for a binary VAT area).  In the dataset including a total of the 12 studies, ADDIN EN.CITE 7,10-20 higher VAT was associated with a statistically significantly increased odds of adenomas compared to lower VAT (OR=1.76, 95% CI=1.41-2.19, I2=53%, Pheterogeneity=0.02) (eFigure 1).  

Subgroup analyses 
In most of the subgroups defined by variables related to potential effect modifiers and methodological qualities, an increase in VAT area remained associated with a statistically significant elevated odds of adenomas, suggesting robustness of the relationship (eTable 3).  In particular, the direct linear relationship was statistically significant regardless of adjustment for BMI and SAT, which suggests that visceral adiposity predicts adenomas independently of other adiposity indices.  None of the stratifying variables explained the observed moderate heterogeneity, but our study is low powered to detect between-subgroup heterogeneity due to the limited number of studies.
Pertaining to etiologic heterogeneity by adenoma subtype, some studies reported that the mean or median VAT area was statistically significantly greater among people with advanced adenomas (diameter ≥ 1 cm, villous component, or high-grade dysplasia) than those with non-advanced adenomas, or that VAT was more strongly associated with advanced adenomas than with non-advanced adenomas (eTable 4).  By respective characteristic of adenomas, greater VAT area appeared to be more consistently associated with large size and multiplicity than with (tubule)villous component and high-grade dysplasia in all seven studies that reported on this.

Highest vs. Lowest Meta-Analysis: VAT in Comparison with Other Adiposity Indices
A positive association between VAT and adenomas remained statistically significant even after adjustment for BMI, WC, or SAT (Figure 3A-C).  Conversely, adjustment for VAT substantially attenuated associations of BMI, WC, and SAT with adenomas (Figure 4A-C).  In a sensitivity analysis that compared summary ORs mutually unadjusted for each of adiposity indices, VAT was generally a stronger predictor than the other adiposity indices, although the magnitudes were not directly comparable (eFigure 2A-C).

Discussion
	In our dose-response meta-analyses of six observational studies, VAT area was linearly associated with the odds of adenomas, with each 25 cm2 increase in VAT area elevating the odds approximately by 13%.  While there was a moderate degree of heterogeneity, it was strongly driven by a single study ADDIN EN.CITE 12 that showed the strongest association among the six studies included.  The direct association was robust, as it remained statistically significant after excluding the study by Kang et al ADDIN EN.CITE 12; in most of the subgroups defined by variables related to potential effect modifiers and methodological aspects; in the highest vs. lowest meta-analysis conducted in the dataset including the six additional studies. ADDIN EN.CITE 15-20  There were was consistent evidence that VAT may be more strongly associated with advanced adenomas.
Our meta-analyses provide strong evidence supporting for the predominant role of VAT in linking excess adiposity and adenomas.  First, a statistically significant direct association between VAT and adenomas persisted even after adjustment for BMI, WC, and SAT, whereas that of adenomas with each of BMI and WC was abolished upon adjustment for VAT. 
Indeed, in a study that simultaneously included three indices BMI, WC, and VAT in the same regression model, only VAT was a statistically significant predictor of adenomas.11  Second, SAT was not associated with adenomas regardless of adjustment for the other adiposity indices.  Third, among summary ORs comparing the extreme categories of each of VAT, BMI, WC, and SAT that were not mutually adjusted for, VAT was the strongest predictor of adenomas.  These findings suggest that the observed associations of BMI and WC with colorectal neoplasia may be due to the correlations of BMI and WC with VAT; the presence of an association between WC and colorectal neoplasia independent of BMI may be attributable to the better capability of WC to capture VAT than BMI.  Indeed, a study showed that VAT was statistically significantly more strongly correlated with WC than with BMI (men: 0.55 vs. 0.46, women: 0.76 vs. 0.60).30  
Our demonstration of the specific contribution of VAT to colorectal neoplasia has an important implications, especially for men.  Compared with women, men have higher VAT ADDIN EN.CITE 30,31 and thus, have a wider range of VAT with more in the top range.  In light of our finding of a linear association between VAT and adenomas and assuming the same association for men and women, adenomas attributable to VAT would be greater among men than among women.  For instance, in a healthy Caucasian population with mean age of 43.3 years, the mean and range of VAT area was 77 (3-290) cm2 for women and 137 (3-482) cm2 for men.30  Based on our finding of 13% increased odds per 25 cm2 increase in VAT area, on average, men would have an approximately 31% increased odds of adenomas compared with women.  Thus, the two factors (a linear association of VAT and adenomas, higher VAT among men) may explain higher rates of colorectal neoplasia observed among men. ADDIN EN.CITE 32  Furthermore, given that Asians have higher VAT than Caucasians for a given BMI due to their lower muscle mass and a tendency toward visceral obesity, ADDIN EN.CITE 33 the two factors may also explain higher rates of colorectal neoplasia observed in Asians in the normal range of BMI. ADDIN EN.CITE 32   
There are several strengths in our dose-response meta-analyses.  First, this is the first meta-analysis that summarized the relationship between VAT and adenomas, demonstrating VAT as a principal mediator of excess adiposity and adenomas above and beyond the overall amount and distribution of adipose tissue.  Second, by performing dose-response meta-analyses, we identified a linear relationship with the odds increasing by 13% for each 25 cm2 increase in VAT area.  Third, confounding by lifestyle factors are less likely to have affected our summary estimates.  As the investigation of VAT and adenomas requires the use of costly medical service such as CT scan and endoscopy, most of the studies included recruited participants from asymptomatic individuals who underwent such procedures for a routine health check-up.  Considering that lifestyle factors including diet and physical activity are important determinants of VAT and adenomas, studies conducted among health-conscious people are less prone to confounding by lifestyle factors.  Fourth, albeit reviewed qualitatively, the consistent observation of a stronger association of VAT with advanced adenomas, which are the likely precursors to most colorectal cancers, suggests that VAT may be implicated in both development and promotion of adenomas.  Finally, publication bias is less of a concern as studies with costly and complex assessment of the exposure and outcome were unlikely to remain un-reported.  
Our dose-response meta-analyses have several limitations as well.  First, while the use of objective measurement of VAT minimized exposure measurement error within each study, the inevitable approximations made to conduct dose-response meta-analyses, as described in the method section, introduced measurement error.  While the direction of bias due to this measurement error cannot be predicted, attenuation of the true effect is generally expected, ADDIN EN.CITE 34 particularly because error in objectively-assessed VAT is likely to be random with respect to disease status.  Second, there is uncertainty about the temporal relationship between visceral obesity and adenomas.  In most of the studies included, measurement of VAT by CT was done on the same day as endoscopy.  Furthermore, as adenomas are asymptomatic, adenomas detected at endoscopy would have been present for a variation of time period.  Thus, a summary OR from our meta-analyses indicates the relative odds of “having” adenomas associated with a difference in VAT area (i.e. prevalence OR).  However, as adenomas are not malignant by themselves, it is unlikely that the presence of undetected adenomas affects VAT, precluding the possibility of reverse causation. 
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Figure 1. Flowchart for study selection
Figure 2. Dose-response meta-analyses of VAT area and adenomas.  (A) Linear dose-response meta-analysis; (B) Non-linear dose-response meta-analysis (reference=30 cm2)
Legend: Inner ticks on the x axis represent data points contributed by the studies included in the meta-analysis
	
Figure 3. Meta-analysis of highest vs. lowest category of VAT and adenomas. (A) By adjustment for BMI; (B) By adjustment for WC; (C) By adjustment for SAT 

Figure 4. Meta-analysis of highest vs. lowest category of other adiposity indices and adenomas by adjustment for VAT. (A) for BMI; (B) for WC; (C) for SAT
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